Faculty profile

Amer Sami

Back to faculty

Clinical ProfessorDepartment of MedicineUniversity of Saskatchewan

Amer Sami

Clinical Professor

Department of Medicine

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
3 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

578

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.
Breast cancer research and treatment · 2026 · senior author
Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study.
Cancers · 2023
Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study.
Scientific reports · 2022

All 12 publications

12 publications.

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Ahmed S, Mannala S, Mondal P, Mahmood W, Chalchal HI, Dwernychuk L, Iqbal N, Salim M, Khan MI, Ahmed O, Manna M, Leverick DG, Chandrasekhar A, Bashir A, Haider K, Leis A, Kontulainen S, Sami A

Breast cancer research and treatment2026Senior author

DOI: 10.1007/s10549-026-07999-1 PMID: 42360361

Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study.

Fisher LAB, Ahmed O, Chalchal HI, Deobald R, El-Gayed A, Graham P, Groot G, Haider K, Iqbal N, Johnson K, Le D, Mahmood S, Manna M, Meiers P, Pauls M, Salim M, Sami A, Wright P, Younis M, Ahmed S

Cancers20232 citationsOpen Access

DOI: 10.3390/cancers15071995 PMID: 37046656

Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study.

Ali S, Hendry J, Le D, Mondal PK, Sami A, Chalchal H, Haider K, Ahmed O, El-Gayed A, Wright P, Pauls M, Johnson K, Ahmed S

Scientific reports202218 citationsOpen Access

DOI: 10.1038/s41598-022-05209-8 PMID: 35058536

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer.

Andrahennadi S, Sami A, Manna M, Pauls M, Ahmed S

Current oncology (Toronto, Ont.)202160 citationsOpen Access

DOI: 10.3390/curroncol28030168 PMID: 34064867

Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC).

Burbridge B, Lim H, Dwernychuk L, Le H, Asif T, Sami A, Ahmed S

Current oncology (Toronto, Ont.)202137 citationsOpen Access

DOI: 10.3390/curroncol28020141 PMID: 33918869

Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience.

Andrahennadi S, Sami A, Haider K, Chalchal HI, Le D, Ahmed O, Manna M, El-Gayed A, Wright P, Ahmed S

Cancers20217 citationsOpen Access

DOI: 10.3390/cancers13164163 PMID: 34439317

Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.

Xie Y, Wu J, Xu A, Ahmeqd S, Sami A, Chibbar R, Freywald A, Zheng C, Xiang J

Vaccine201830 citations

DOI: 10.1016/j.vaccine.2018.01.078 PMID: 29415817

HER2-directed therapy: current treatment options for HER2-positive breast cancer.

Ahmed S, Sami A, Xiang J

Breast cancer (Tokyo, Japan)2015185 citations

DOI: 10.1007/s12282-015-0587-x PMID: 25634227

Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.

Wang L, Xie Y, Ahmed KA, Ahmed S, Sami A, Chibbar R, Xu Q, Kane SE, Hao S, Mulligan SJ, Xiang J

Breast cancer research and treatment201349 citations

DOI: 10.1007/s10549-013-2626-7 PMID: 23881522

Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.

Ahmed S, Ahmad I, Zhu T, Arnold FP, Faiz Anan G, Sami A, Yadav SK, Alvi R, Haider K

Diseases of the colon and rectum201053 citations

DOI: 10.1007/dcr.0b013e3181e78815 PMID: 20847626

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Amer Sami

Research

Latest papers

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study.

Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study.

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer.

Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC).

Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience.

Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.

HER2-directed therapy: current treatment options for HER2-positive breast cancer.

Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.

Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.

Frequent collaborators

Shahid Ahmed

Kamal Haider

Osama Ahmed

Mita Manna

Jim Xiang

Muhammad Salim

Nayyer Iqbal

Kate Johnson

Brent Burbridge

Ayesha Bashir

Haji Chalchal

Andrew Freywald

Saija Kontulainen

Gary Groot

Anne Leis